Two Authors Reply
TL;DR: The authors thank Drs.
read more
Abstract: We thank Drs. Knowles and Reaven for their insightful letter (1), which meaningfully adds to the debate regarding uric acid as a biomarker of risk of or causal factor for cardiovascular disease. Here are a few additional observations to add to this discussion.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Marilda Mazzali,Jeremy Hughes,Yoon Goo Kim,J. Ashley Jefferson,Duk Hee Kang,Katherine L. Gordon,Hui Y. Lan,Salah D. Kivlighn,Richard J. Johnson +8 more
TL;DR: Mild hyperuricemia causes hypertension and renal injury in the rat via a crystal-independent mechanism, with stimulation of the renin-angiotensin system and inhibition of neuronal NO synthase.
1.3K
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial
TL;DR: In this paper, a crossover study of adolescents with newly diagnosed hypertension, treatment with allopurinol resulted in reduction of BP, although not a fully developed therapeutic strategy due to potential adverse effects.
904
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism
Marilda Mazzali,John Kanellis,Lin Han,Lili Feng,Yi Yang Xia,Qiang Chen,Duk Hee Kang,Katherine L. Gordon,Susumu Watanabe,Takahiko Nakagawa,Hui Y. Lan,Richard J. Johnson +11 more
TL;DR: Hyperuricemia induces a renal arteriolopathy in rats that is blood pressure independent and involves the renin-angiotensin system, and this was partially inhibited by losartan.
863
Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid Level
TL;DR: Allopurinol therapy significantly decreases serum uric acid levels in hyperuricemic patients with mild to moderate chronic kidney disease and helps preserve kidney function during 12 months of therapy compared with controls.
855
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea,Soledad García de Vinuesa,Ursula Verdalles,Caridad Ruiz-Caro,Jara Ampuero,Abraham Rincón,David Arroyo,José Luño +7 more
TL;DR: Allopurinol decreases C-reactive protein and slows down the progression of renal disease in patients with chronic kidney disease and reduces cardiovascular and hospitalization risk in these subjects.
821